(Q39441667)

12 September 2017

title

Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential (English)

1 reference

12 September 2017

main subject

mesenchymal stem cell

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Vladislav Volarevic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Nemanja U Jovicic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Valentin Djonov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Nebojsa Arsenijevic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Marina Gazdic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Bojana Simovic Markovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

1 reference

18 July 2017

1 reference

12 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

633-644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus

5 June 2020

cites work

1 reference

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells

21 January 2018

1 reference

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy

21 January 2018

1 reference

Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue

21 January 2018

1 reference

Human stem cell research and regenerative medicine--present and future.

21 January 2018

1 reference

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

21 January 2018

1 reference

Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis

21 January 2018

1 reference

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis

21 January 2018

1 reference

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

Immunoregulation by members of the TGFβ superfamily

21 January 2018

1 reference

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.

21 January 2018

1 reference

Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion

21 January 2018

1 reference

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

21 January 2018

1 reference

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

Umbilical Cord-derived Mesenchymal Stem Cells Instruct Monocytes Towards an IL10-producing Phenotype by Secreting IL6 and HGF

21 January 2018

1 reference

Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model.

21 January 2018

1 reference

Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

21 January 2018

1 reference

Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD.

21 January 2018

1 reference

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

Mesenchymal stem cells: a double-edged sword in regulating immune responses

21 January 2018

1 reference

Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.

21 January 2018

1 reference

Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.

21 January 2018

1 reference

The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice

21 January 2018

1 reference

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis

21 January 2018

1 reference

IL-10: the master regulator of immunity to infection

21 January 2018

1 reference

Retracted: Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway

21 January 2018

1 reference

Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.

21 January 2018

1 reference

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes

21 January 2018

1 reference

Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects

21 January 2018

1 reference

Crosstalk between mesenchymal stem cells and endothelial cells leads to downregulation of cytokine-induced leukocyte recruitment

21 January 2018

1 reference

IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis

21 January 2018

1 reference

Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy.

21 January 2018

1 reference

Regulation of liver regeneration by growth factors and cytokines

21 January 2018

1 reference

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations

21 January 2018

1 reference

The roles of Galectin-3 in autoimmunity and tumor progression

21 January 2018

1 reference

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

21 January 2018

1 reference

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation

21 January 2018

1 reference

Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula

21 January 2018

1 reference

Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study

21 January 2018

1 reference

Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial

21 January 2018

1 reference

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

21 January 2018

1 reference

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.

21 January 2018

1 reference

TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity

21 January 2018

1 reference

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

21 January 2018

1 reference

MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6.

21 January 2018

1 reference

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.

21 January 2018

1 reference

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

HLA-G and immune tolerance in pregnancy

21 January 2018

1 reference

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

21 January 2018

1 reference

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.

21 January 2018

1 reference

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

21 January 2018

1 reference

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

21 January 2018

1 reference

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile

21 January 2018

1 reference

Neuroimmune regulation during intestinal development and homeostasis

21 January 2018

1 reference

Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice

21 January 2018

1 reference

Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β

21 January 2018

1 reference

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIOF.1374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28718997%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference